Product
PCI 32765
1 clinical trial
4 indications
Indication
LeukemiaIndication
LymphocyticIndication
Chronic Lymphocytic LeukemiaIndication
Small Lymphocytic LymphomaClinical trial
A Phase II Study of PCI-32765 for Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Need Therapy and Are Older Than 65 or Have a 17p DeletionStatus: Active (not recruiting), Estimated PCD: 2014-06-20